[MBSB] QoQ TTM Result on 30-Sep-2014 [#3]

Stock
[MBSB] MBSB BERHAD
Announcement Date
03-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 8.57%
YoY- 16.67%
Quarter Report
Latest QR
Upcoming QR
MBSB's Result
MBSB's Financial Summary
View:
Show?
TTM Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 2,729,705 2,636,004 2,612,512 2,738,923 2,703,966 2,646,182 2,541,547 4.89%
PBT 641,622 823,244 932,556 1,096,689 1,025,506 962,203 932,349 -22.10%
Tax 153,684 119,363 82,473 -341,184 -329,648 -334,095 -334,831 -
NP 795,306 942,607 1,015,029 755,505 695,858 628,108 597,518 21.06%
-
NP to SH 795,306 942,607 1,015,029 755,505 695,858 628,108 597,518 21.06%
-
Tax Rate -23.95% -14.50% -8.84% 31.11% 32.14% 34.72% 35.91% -
Total Cost 1,934,399 1,693,397 1,597,483 1,983,418 2,008,108 2,018,074 1,944,029 -0.33%
-
Net Worth 4,253,614 4,807,542 4,665,300 4,225,942 3,964,586 3,426,744 2,180,702 56.30%
Dividend
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Div 323,960 323,960 323,960 87,172 174,031 174,031 174,031 51.49%
Div Payout % 40.73% 34.37% 31.92% 11.54% 25.01% 27.71% 29.13% -
Equity
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Net Worth 4,253,614 4,807,542 4,665,300 4,225,942 3,964,586 3,426,744 2,180,702 56.30%
NOSH 2,508,914 2,708,322 2,699,670 2,675,493 2,631,129 2,350,465 1,743,446 27.54%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 29.14% 35.76% 38.85% 27.58% 25.73% 23.74% 23.51% -
ROE 18.70% 19.61% 21.76% 17.88% 17.55% 18.33% 27.40% -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 108.80 97.33 96.77 102.37 102.77 112.58 145.78 -17.76%
EPS 31.70 34.80 37.60 28.24 26.45 26.72 34.27 -5.07%
DPS 12.91 11.96 12.00 3.26 6.61 7.40 9.98 18.77%
NAPS 1.6954 1.7751 1.7281 1.5795 1.5068 1.4579 1.2508 22.54%
Adjusted Per Share Value based on latest NOSH - 2,675,493
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 33.20 32.06 31.77 33.31 32.89 32.18 30.91 4.89%
EPS 9.67 11.46 12.34 9.19 8.46 7.64 7.27 21.01%
DPS 3.94 3.94 3.94 1.06 2.12 2.12 2.12 51.33%
NAPS 0.5173 0.5847 0.5674 0.514 0.4822 0.4168 0.2652 56.30%
Price Multiplier on Financial Quarter End Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 -
Price 1.69 2.19 2.43 2.45 2.17 2.18 2.21 -
P/RPS 1.55 2.25 2.51 2.39 2.11 1.94 1.52 1.31%
P/EPS 5.33 6.29 6.46 8.68 8.21 8.16 6.45 -11.97%
EY 18.76 15.89 15.47 11.53 12.19 12.26 15.51 13.56%
DY 7.64 5.46 4.94 1.33 3.05 3.40 4.52 42.03%
P/NAPS 1.00 1.23 1.41 1.55 1.44 1.50 1.77 -31.72%
Price Multiplier on Announcement Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 06/08/15 07/05/15 16/02/15 03/11/14 14/08/14 15/05/14 28/01/14 -
Price 1.72 2.01 2.25 2.59 2.41 2.17 2.13 -
P/RPS 1.58 2.07 2.33 2.53 2.35 1.93 1.46 5.42%
P/EPS 5.43 5.78 5.98 9.17 9.11 8.12 6.21 -8.58%
EY 18.43 17.32 16.71 10.90 10.97 12.31 16.09 9.50%
DY 7.51 5.95 5.33 1.26 2.74 3.41 4.69 36.98%
P/NAPS 1.01 1.13 1.30 1.64 1.60 1.49 1.70 -29.39%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment